BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors

Journal of Nuclear Medicine

Volumn 41, Issue 1, 2000, Pages 169-176

  Melo, Tricia ^b   Duncan, Jill ^b   Ballinger, James R ^b   Rauth, A Michael ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b NONE

Author keywords

99mTc; Hypoxia; Nitroimidazole; Tumors

Indexed keywords

2 NITROIMIDAZOLE DERIVATIVE; TECHNETIUM 99M;

ANIMAL CELL; ARTICLE; CHO CELL; DIAGNOSTIC IMAGING; HYPOXIA; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; TUMOR; TUMOR BLOOD FLOW;

ANIMALS; CELL HYPOXIA; CHO CELLS; CRICETINAE; FEMALE; IMIDAZOLES; MALE; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NITROIMIDAZOLES; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 0033959159     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Linder KE, Chan Y-W, Cyr JE, Malley MF, Nowotnik DP, Nunn AD. TcO(PnAO-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction. J Med Chem. 1994;37:9-17.
2. Nunn A, Linder K, Strauss HW. Nitroimidazoles and imaging hypoxia. Eur J Nucl Med. 1995;22:265-280.
3. DiRocco RJ, Kuczynski BL, Pirro JP, et al. Imaging ischemic tissue at risk of infarction during stroke. J Cereb Blood Flow Metab. 1993;13:755-762.
4. 99mTc]technetium-labeled nitroheterocycle capable of identification of hypoxia in heart. Biochem Biophys Res Commun. 1993;193:1239-1246.
5. Kusuoka H, Hashimoto K, Fukuchi K, Nishimura T. Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium. J Nucl Med. 1994;35:1371-1376.
6. Rumsey WL, Kuczynski B, Patel B, et al. SPECT imaging of ischemic myocardium using a technetium-99m-nitroimidazole ligand. J Nucl Med. 1995;36: 1445-1450.
7. Ng CK, Sinusas AJ, Zaret BL, Stoufer R. Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia. Circulation. 1995;92:1261-1268.
8. Ballinger JR, Wan Min Kee J, Rauth AM. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia. J Nucl Med. 1996;37:1023-1031.
9. Okada RD, Nguyen KN, Strauss HW, Johnson G. Effects of low flow and hypoxia on myocardial retention of technetium-99m BMS181321. Eur J Nucl Med. 1996;23:443-447.
10. Fukuchi K, Kusuoka H, Watanabe Y, Fujiwara T, Nishimura T. Ischemic and reperfused myocardium detected with technetium-99m-nitroimidazole. J Nucl Med. 1996;37:761-766.
11. DiRocco RJ, Bauer AA, Pirro JP, et al. Delineation of the border zone of ischemic rabbit myocardium by a technetium-labeled nitroimidazole. Nucl Med Biol. 1997;24:201-207.
12. Barron B, Grotta J, Lamki L, et al. Preliminary experience with technetium-99m BMS-181321, a nitroimidazole, in the detection of cerebral ischemia associated with acute stroke [abstract]. J Nucl Med. 1996;37(suppl):272P-273P.
13. Wedeking P, Yost F, Wen M, et al. Comparison of the biologic activity of the isomers of the Tc-99m-nitroimidazole complex BMS-194796 [abstract]. J Nucl Med. 1995;36(suppl):17P.
14. Johnson LL, Schofield L, Mastrofrancesco P, Donahay T, Nott L. Technetium-99m-nitroimidazole uptake in a swine model of demand ischemia. J Nucl Med. 1998;39:1468-1475.
15. Ballinger JR, Cowan DSM, Boxen I, Zhang ZM, Rauth AM. Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitro. J Nucl Med. 1993;34:242-245.
16. Cowan DSM, Melo T, Park L, Ballinger JR, Rauth AM. BMS181321 accumulation in rodent and human cells: the role of P-glycoprotein. Br J Cancer. 1996;74(suppl):S264-S266.
17. Melo T, Hua HA, Ballinger JR, Rauth AM. Modifying the in vitro accumulation of BMS181321, a technetium-99m-nitroimidazole, with unlabelled nitroaromatics. Biochem Pharmacol. 1997;54:685-693.
18. Wood PJ, Stratford IJ, Adams GE, Szabo C, Thiemermann C, Vane JR. Modification of energy metabolism and radiation response of a murine tumor by changes to nitric oxide availability. Biochem Biophys Res Commun. 1993;192:505-510.
19. 18F]-fluoromisonidazole. Int J Radiat Oncol Biol Phys. 1991;22:199-212.
20. 123I-iodoazomycin arabinoside: preliminary report of a clinical study. Br J Cancer. 1992;65:90-95.
21. Archer CM, Edwards B, Kelly JD, King AC, Burke JF, Riley ALM. Technetium-labelled agents for imaging tissue hypoxia in vivo. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and Rhenium in Chemistry and Nuclear Medicine. Padova, Italy: SG Editoriali; 1995:535-539.
22. 99mTc-HL91: effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent. Circulation. 1997;95:1892-1899.
23. Cook GJR, Houston S, Barrington SF, Fogelman I. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG. J Nucl Med. 1998;39:99-103.
24. McEwan AJB, Catz Z, Morin C, Wiebe LI. Hypoxia imaging in patients with breast cancer [abstract]. Eur J Nucl Med. 1997;24:1028.
25. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advance squamous cell carcinoma of the head and neck. Radiother Oncol. 1996;41:31-39.
26. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997;38:285-289.
27. Overgaard J, Horsman MR. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol. 1996;6: 10-21.
28. Grunbaum Z, Freauff SJ, Krohn KA, Wilbur DS, Magee S, Rasey JS. Synthesis and characterization of congeners of misonidazole for imaging hypoxia. J Nucl Med. 1987;28:68-75.
29. Mannan RH, Somayaji VV, Lee J, Mercer JR, Chapman JD, Wiebe LI. Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia. J Nucl Med. 1991;32:1764-1770.
30. McEwan AJB, Skeith KJ, Mannan RH, et al. I-123 iodoazomycin arabinoside (IAZA) may have a role in imaging rheumatoid arthritis [abstract]. J Nucl Med. 1997;38(suppl):300P-301P.
31. Liu R-S, Chu L-C, Yen S-H, et al. Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole. Eur J Nucl Med. 1996;23:1384-1387.